Vivira Health Lab GmbH develops and markets digital health applications (DiGA) focused on musculoskeletal disorders. Their mission is to help people reduce pain and restore physical function through digital therapy programs.

Their flagship product is ViViRA, the most prescribed app on prescription for back pain, offering guideline-compliant, movement-therapeutic training for pain reduction based on functional training principles. It is a CE-marked medical device and permanently listed by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application.

Founded in 2015 and headquartered in Berlin and Munich, Vivira Health Lab aims to bring effective, simple movement therapy to as many people as possible.

ViViRA provides personalized therapeutic training accessible anytime and anywhere with daily guided exercises, weekly progress checks, and monthly mobility tests. It is considered an alternative to physiotherapy and can complement conventional therapies.

The company prioritizes medical efficacy, patient safety, data protection, and information security, holding ISO 13485 and ISO 27001 certifications.

Vivira Health Lab's app costs are covered by all statutory health insurance companies and most private insurers in Germany, with the possibility of reimbursement for eligible individuals.